Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 to 43 who have been diagnosed with stage 3 or 4 endometriosis (the more advanced stages of the condition), as defined by a recognised medical classification system — this is the "case" group.
- Women aged 18 to 43 whose fertility difficulties are caused by their male partner's infertility, and who have been confirmed through tests to not have endometriosis — this is the "control" (comparison) group.
- Women who have not taken antibiotics in the three months before joining the trial and are not currently taking part in any other medication-based study.
- Women who are covered by the French national social security health insurance scheme.
- Women who have read about the study, had time to think it over freely, and have signed a form agreeing to take part.
Who may not be able to join:
- Women aged 44 or older.
- Women who are overweight, obese, or have anorexia.
- Women who have taken antibiotics in the three months before joining, or who are currently taking part in another drug trial.
- Women who are currently taking a type of hormone treatment called anti-GnRH, who are pregnant, or who have a long-term inflammatory condition such as Crohn's disease or polycystic ovary syndrome (confirm with trial site for full list of conditions).
- Women whose endometriosis has not been officially confirmed through tests carried out by the specific reproductive medicine department running this trial.
- Women who are under a legal protection arrangement such as guardianship or court-appointed supervision.
- Women who have not signed the written consent form agreeing to take part in the study.
- Women who later decide to withdraw their agreement to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 33+3 22 08 73 72
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
quantification of circulating free DNA (cfDNA) between both groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.